• Edwards Lifesciences CEO Bernard J. Zovighian sold 523 common shares on June 17, 2026 at USD 87.92.
• Sale was reported as indirect ownership held by a trust; trust holdings fell to 11,516 shares.
• Zovighian reported direct ownership of 99,164 shares following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001225208-26-006103), on June 17, 2026, and is solely responsible for the information contained therein.